GGrantIndex
Sort

39,280 grants matching leukemia

CORE--GASTROENTEROLOGY

$346,443
Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA

CORE--BIOSTATISTICS

$346,443
Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA

CORE--POSTTRANSPLANT

$346,443
Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA

PREVENTION AND TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE

$346,443
Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA

PATHOPHYSIOLOGY AND PREVENTION OF MULTIORGAN FAILURE

$346,443
Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA

TREATMENT OF MALIGNANCY WITH GENE MODIFIED T CELLS AND T CELL CLONES

$346,443
Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA

CORE--PATHOLOGY

$346,443
Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA

Chemotherapy, Pain, Sleep, Fatigue in Children & Parents

$346,372
Vivian R. Gedaly-Duff · Oregon Health & Science University · R01 · FY2009 · NR

New perspective on MyoD function and differentiation in rhabdomyosarcoma

$346,364
Denis C Guttridge · Medical University Of South Carolina · R01 · FY2023 · CA

Anticancer peptide therapeutics

$346,350
Yin Wang · University Of Maryland Baltimore · R01 · FY2022 · CA

Redefining the major peanut allergens

$346,335
Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2007 · AI

Repression via Facultative Heterochromatin

$346,334
Danny F Reinberg · University Of Miami School Of Medicine · R01 · FY2024 · CA

Endocrine disrupter modulation of SXR in development and lymphomagenesis

$346,313
Bruce Blumberg · University Of California-Irvine · R01 · FY2013 · ES

Human engineered enzymes for L-Arg depletion chemotherapy

$346,306
George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2010 · CA

Targeting the GFI1-LSD1 Axis in T-Cell Acute Lymphoblastic Leukemia

$346,271
Michael E Engel · University Of Utah · R01 · FY2017 · CA

MODULATION OF MULTIDRUG RESISTANCE MECHANISMS

$346,226
Stanford University · R01 · FY2000 · CA

The influence of proteostasis loss in aging hematopoietic stem cells on leukemia initiation

$346,224
Robert A.j. Signer · University Of California, San Diego · U01 · FY2024 · CA

Humoral and cellular immunity in polyomavirus-linked Merkel cell carcinoma

$346,175
Paul Nghiem · University Of Washington · R01 · FY2011 · CA

Integration of epigenetic and non-coding RNA mechanisms in leukemia

$346,144
Sara E Meyer · Thomas Jefferson University · R37 · FY2019 · CA

Elucidation of Human Natural Killer Cell Development

$346,144
Aharon G Freud · Ohio State University · R01 · FY2019 · CA

Targeting Cdc42 for bone marrow transplant therapies

$346,144
Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA

Dendritic Cell Subsets and Paths of Maturation in GVHD

$346,142
Warren D Shlomchik · Yale University · P01 · FY2009 · AI

Chaetocin as a Potential Therapy for Multiple Myeloma

$346,123
Keith C Bible · Mayo Clinic Rochester · R01 · FY2012 · CA

Characterization of the Role of ADAR1 in Oncogenic Transformation of Progenitors

$346,108
Catriona Helen Macleod Jamieson · University Of California, San Diego · R01 · FY2017 · CA

How Insulin/IGF-1 Deficiencies Retard Mammalian Aging

$346,070
David E Harrison · Jackson Laboratory · R01 · FY2010 · AG